IDSA: ACA Improving Care for Low-Income HIV Patients

This article originally appeared here.
Share this content:
IDSA: ACA Improving Care for Low-Income HIV Patients
IDSA: ACA Improving Care for Low-Income HIV Patients

FRIDAY, Oct. 9, 2015 (HealthDay News) -- Low-income HIV patients who enrolled in the Affordable Care Act (ACA) may be faring better than they did on traditional state assistance, according to a study scheduled for presentation at the annual meeting of the Infectious Diseases Society of America (IDWeek), held from Oct. 7 to 11 in San Diego.

The findings are based on a two-year study of 3,933 Virginia AIDS Drug Assistance Program (ADAP) patients who were eligible to move to an ACA health plan in 2014.

The researchers found that, overall, 47 percent of patients made the switch. And, patients who made the switch increased their odds of achieving HIV viral suppression by 45 percent compared to patients who stayed with ADAP.

"Given what we found, it's unfortunate that less than half of those patients enrolled in an ACA plan," lead researcher Kathleen McManus, M.D., a fellow at the University of Virginia School of Medicine in Charlottesville, Va., told HealthDay. One of the next steps, she added, will be to figure out what keeps patients from enrolling.

Abstract
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

Congress Approves Bill Expanding Private Care for VA Patients

Congress Approves Bill Expanding Private Care for VA ...

New bill would open up access to private doctors for veterans

AAP Recommending Injectable Flu Shot for 2018-19 Flu Season

AAP Recommending Injectable Flu Shot for 2018-19 Flu ...

Children should receive injectable vaccine, which has been shown to be more consistently effective

Neurologists Identify New Type of Vertigo

Neurologists Identify New Type of Vertigo

Long-term prognosis favorable, with improvement of symptoms in more than half of patients